Veldoreotide, a remarkable synthetic somatostatin analog widely employed in the field of biomedicine, emerges as an imperative therapeutic agent bestowed with exquisite properties. Ostensibly tailored to combat acromegaly, an endocrine anomaly resultant from the relentless surge in growth hormone secretion, Veldoreotide orchestrates its profound efficacy through the judicious inhibition of growth hormone release. Through such a meticulously orchestrated mechanism, the subject in question undeniably manifests potential in permeating symptomatic alleviation, targeting the resolution of presumably incapacitating manifestations encompassing the elongation of appendages, including hands and feet, as well as pertinent facial metamorphoses.
CAT No: R1984
CAS No:252845-37-7
Synonyms/Alias:Veldoreotide;Somatoprim;252845-37-7;Veldoreotide [USAN];COR-005;PTR 3173;UNII-1Z83587HBN;1Z83587HBN;VELDOREOTIDE [INN];DG 3173;VELDOREOTIDE [WHO-DD];PTR-3173;DG3173;2-[(3S,6S,9S,12R,15S,18S)-9-(4-Aminobutyl)-3,18-dibenzyl-6-[(1R)-1-hydroxyethyl]-12,15-bis(1H-indol-3-ylmethyl)-2,5,8,11,14,17,20,25-octaoxo-1,4,7,10,13,16,19,24-octazacyclooctacos-1-yl]acetamide;DG-3173;veldoreotida;2-[(3S,6S,9S,12R,15S,18S)-9-(4-aminobutyl)-6-(1-hydroxyethyl)-12,15-bis(1H-indol-3-ylmethyl)-2,5,8,11,14,17,20,25-octaoxo-3,18-bis(phenylmethyl)-1,4,7,10,13,16,19,24-octazacyclooctacos-1-yl]acetamide;GLYCINAMIDE, N-(4-AMINO-1-OXOBUTYL)-L-PHENYLALANYL-L-TRYPTOPHYL-D-TRYPTOPHYL-L-LYSYL-L-THREONYL-L-PHENYLALANYL-N2-(3-CARBOXYPROPYL)-, (7->1)-LACTAM;N4.1-(2-AMINO-2-OXOETHYL)-CYCLO(4-AMINOBUTANOYL-4-AMINOBUTANOYL-L-PHENYLALANYL-L-TRYPTOPHYL-D-TRYPTOPHYL-L-LYSYL-L-THREONYL-L-PHENYLALANYL);veldoreotidum;2-((3S,6S,9S,12R,15S,18S)-9-(4-aminobutyl)-3,18-dibenzyl-6-((1R)-1-hydroxyethyl)-12,15-bis((1H-indol-3-yl)methyl)-2,5,8,11,14,17,20,25-octaoxo-1,4,7,10,13,16,19,24-octaazacyclooctacosan-1-yl)acetamide;2-((3S,6S,9S,12R,15S,18S)-9-(4-aminobutyl)-6-(1-hydroxyethyl)-12,15-bis(1H-indol-3-ylmethyl)-2,5,8,11,14,17,20,25-octaoxo-3,18-bis(phenylmethyl)-1,4,7,10,13,16,19,24-octazacyclooctacos-1-yl)acetamide;2-[(3S,6S,9S,12R,15S,18S)-9-(4-aminobutyl)-3,18-dibenzyl-6-[(1R)-1-hydroxyethyl]-12,15-bis[(1H-indol-3-yl)methyl]-2,5,8,11,14,17,20,25-octaoxo-1,4,7,10,13,16,19,24-octaazacyclooctacosan-1-yl]acetamide;GTPL8487;GLXC-20851;EX-A7913;HY-P0024;DB12777;DA-78857;CS-0012831;Q27253298;
Chemical Name:2-[(3S,6S,9S,12R,15S,18S)-9-(4-aminobutyl)-3,18-dibenzyl-6-[(1R)-1-hydroxyethyl]-12,15-bis(1H-indol-3-ylmethyl)-2,5,8,11,14,17,20,25-octaoxo-1,4,7,10,13,16,19,24-octazacyclooctacos-1-yl]acetamide
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More